Article In: orcid, cienciavitae
Pre-miRNA-149 G-quadruplex as a molecular agent to capture nucleolin
European Journal of Pharmaceutical Sciences
2022 — Elsevier
—Key information
Authors:
Published in
February 2022
Abstract
One of the most significant challenges in capturing and detecting biomarkers is the choice of an appropriate biomolecular receptor. Recently, RNA G-quadruplexes emerged as plausible receptors due to their ability to recognize with high-affinity proteins. Herein, we have unveiled and characterized the capability of the precursor microRNA 149 to form a G-quadruplex structure and determined the role that some ligands may have in its folding and binding capacity to nucleolin. The G-quadruplex formation was induced by K+ ions and stabilized by ligands, as demonstrated by nuclear magnetic resonance and circular dichroism experiments. Surface plasmon resonance measurements showed a binding affinity of precursor microRNA 149 towards ligands in the micromolar range (10−5–10−6 M) and a strong binding affinity to nucleolin RNA-binding domains 1 and 2 (8.38 × 10−10 M). Even in the presence of the ligand PhenDC3, the binding remains almost identical and in the same order of magnitude (4.46 × 10−10 M). The molecular interactions of the RNA G-quadruplex motif found in precursor miRNA 149 (5′-GGGAGGGAGGGACGGG- 3′) and nucleolin RNA-binding domains 1 and 2 were explored by means of molecular docking and molecular dynamics studies. The results showed that RNA G-quadruplex binds to a cavity between domains 1 and 2 of the protein. Then, complex formation was also evaluated through polyacrylamide gel electrophoresis. The results suggest that precursor microRNA 149/ligands and precursor microRNA 149/nucleolin RNA-binding domains 1 and 2 form stable molecular complexes. The in vitro co-localization of precursor microRNA 149 and nucleolin in PC3 cells was demonstrated using confocal microscopy. Finally, a rapid and straightforward microfluidic strategy was employed to check the ability of precursor microRNA 149 to capture nucleolin RNA-binding domains 1 and 2. The results revealed that precursor microRNA 149 can capture nucleolin RNA-binding domains 1 and 2 labeled with Fluorescein 5-isothiocyanate in a concentration-dependent manner, but PhenDC3 complexation seems to decrease the ability of precursor microRNA 149 to capture the protein. Overall, our results proved the formation of the G-quadruplex structure in the precursor microRNA 149 and the ability to recognize and detect nucleolin. This proof-of-concept study could open up a new framework for developing new strategies to design improved molecular receptors for capture and detection of nucleolin in complex biological samples.
Publication details
Authors in the community:
António Manuel Rocha Paulo
ist126677
Publication version
AO - Author's Original
Publisher
Elsevier
Link to the publisher's version
https://www.sciencedirect.com/journal/european-journal-of-pharmaceutical-sciences
Title of the publication container
European Journal of Pharmaceutical Sciences
First page or article number
106093
Volume
169
ISSN
0928-0987
WoS (Web of Science)
Fields of Science and Technology (FOS)
clinical-medicine - Clinical medicine
Keywords
- Pre-miRNA-149
- RNA G-quadruplex
- Nucleolin
- G-quadruplex ligands
- Molecular receptors,
Publication language (ISO code)
eng - English
Alternative identifier (URI)
http://dx.doi.org/10.1016/j.ejps.2021.106093
Rights type:
Only metadata available